In post stroke patients, treatment with nefiracetam decreases the severity of apathy.
Phase of Trial: Phase II
Latest Information Update: 20 Jan 2017
At a glance
- Drugs Nefiracetam (Primary)
- Indications Depressive disorders
- Focus Therapeutic Use
- 19 Jan 2017 Status changed from recruiting to completed.
- 17 Sep 2012 New source identified and integrated (Australian New Zealand Clinical Trials Registry record: ACTRN12609000975291).
- 06 May 2011 New trial record